Scarica l'app Stockscreener
1.2629
1.53%
-0.0071
Precedente Chiudi:
$1.27
Aprire:
$1.29
Volume 24 ore:
109.29K
Relative Volume:
0.43
Capitalizzazione di mercato:
$22.68M
Reddito:
-
Utile/perdita netta:
$-8.29M
Rapporto P/E:
-1.8041
EPS:
-0.7
Flusso di cassa netto:
$-6.47M
1 W Prestazione:
-14.34%
1M Prestazione:
-18.26%
6M Prestazione:
-30.13%
1 anno Prestazione:
-6.67%
Intervallo 1D:
$1.23
$1.29
Intervallo di 1 settimana:
$1.22
$1.56
Portata 52W:
$0.94
$2.2299
NanoViricides Inc Stock (NNVC) Company Profile
Nome
NanoViricides Inc
Settore
Industria
Telefono
203-937-6137
Indirizzo
1 Controls Drive, Shelton, CT
Confronta NNVC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.26 | 25.37M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.54 | 108.28B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
763.80 | 79.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.84 | 57.65B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
903.51 | 56.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.78 | 42.39B | 447.02M | -1.18B | -906.14M | -6.1812 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2015-02-11 | Iniziato | Midtown Partners | Strong Buy |
NanoViricides Inc Borsa (NNVC) Ultime notizie
NanoViricides, Inc. Has Filed its Quarterly ReportSubsequent Raise Has Fortified Fiscal Position - The News Leader | Staunton, VA
NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd - The Commercial Appeal
Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive - Massillon Independent
Why NanoViricides Inc. (NV3P) stock stays resilient2025 Stock Rankings & Precise Swing Trade Entry Alerts - newser.com
Why NanoViricides Inc. stock stays resilientPortfolio Value Report & Technical Confirmation Trade Alerts - newser.com
Will NanoViricides Inc. stock recover faster than industryJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com
Why NanoViricides Inc. stock is trending on social media2025 Market Overview & Safe Entry Point Identification - newser.com
Will NanoViricides Inc. stock continue upward momentumJuly 2025 PreEarnings & Free Fast Entry Momentum Trade Alerts - newser.com
Can NanoViricides Inc. (NV3P) stock ride next bull market cycleWeekly Trade Analysis & Weekly High Conviction Ideas - newser.com
Is NanoViricides Inc. (NV3P) stock supported by free cash flow2025 Market Outlook & Growth Focused Investment Plans - newser.com
NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo - Erie Times-News
Will NanoViricides Inc. stock sustain bullish trend into 20252025 Year in Review & Technical Confirmation Trade Alerts - newser.com
Is NanoViricides Inc. (NV3P) stock a good hedge against inflationTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Will NanoViricides Inc. stock boost dividends furtherMarket Risk Summary & Community Consensus Picks - newser.com
Is NanoViricides Inc. stock a buy before product launchesJuly 2025 Trends & Free Real-Time Market Sentiment Alerts - newser.com
Published on: 2025-11-19 20:46:00 - newser.com
Why institutional investors increase stakes in NanoViricides Inc. (NV3P) stockEarnings Risk Report & Risk Controlled Swing Trade Alerts - newser.com
How NanoViricides Inc. stock trades after earnings2025 Year in Review & Expert-Curated Trade Recommendations - newser.com
Can NanoViricides Inc. stock hit consensus price targetsTrade Performance Summary & Risk Controlled Swing Alerts - newser.com
Shelton biotech raises $6M in direct offering, but warns of limited cash runway - Hartford Business Journal
NanoViricides Inc Azioni (NNVC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):